1. Home
  2. TMDX vs CAKE Comparison

TMDX vs CAKE Comparison

Compare TMDX & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • CAKE
  • Stock Information
  • Founded
  • TMDX 1998
  • CAKE 1972
  • Country
  • TMDX United States
  • CAKE United States
  • Employees
  • TMDX N/A
  • CAKE N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CAKE Restaurants
  • Sector
  • TMDX Health Care
  • CAKE Consumer Discretionary
  • Exchange
  • TMDX Nasdaq
  • CAKE Nasdaq
  • Market Cap
  • TMDX 2.1B
  • CAKE 2.5B
  • IPO Year
  • TMDX 2019
  • CAKE 1992
  • Fundamental
  • Price
  • TMDX $57.20
  • CAKE $48.76
  • Analyst Decision
  • TMDX Buy
  • CAKE Hold
  • Analyst Count
  • TMDX 11
  • CAKE 16
  • Target Price
  • TMDX $116.10
  • CAKE $47.67
  • AVG Volume (30 Days)
  • TMDX 2.6M
  • CAKE 1.2M
  • Earning Date
  • TMDX 02-24-2025
  • CAKE 02-19-2025
  • Dividend Yield
  • TMDX N/A
  • CAKE 2.21%
  • EPS Growth
  • TMDX N/A
  • CAKE 52.49
  • EPS
  • TMDX 0.94
  • CAKE 2.64
  • Revenue
  • TMDX $401,090,000.00
  • CAKE $3,537,745,000.00
  • Revenue This Year
  • TMDX $81.61
  • CAKE $5.95
  • Revenue Next Year
  • TMDX $22.52
  • CAKE $5.32
  • P/E Ratio
  • TMDX $61.04
  • CAKE $18.48
  • Revenue Growth
  • TMDX 109.09
  • CAKE 2.39
  • 52 Week Low
  • TMDX $56.03
  • CAKE $32.30
  • 52 Week High
  • TMDX $177.37
  • CAKE $52.10
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 35.74
  • CAKE 49.99
  • Support Level
  • TMDX $58.40
  • CAKE $47.88
  • Resistance Level
  • TMDX $67.80
  • CAKE $51.00
  • Average True Range (ATR)
  • TMDX 4.59
  • CAKE 1.40
  • MACD
  • TMDX -0.27
  • CAKE -0.11
  • Stochastic Oscillator
  • TMDX 4.44
  • CAKE 38.63

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

Share on Social Networks: